Visgeneer Inc. (TPEX:4197)
Taiwan · Delayed Price · Currency is TWD 8.57
0.00 (0.00%)
Aug 18, 2026, 1:43 PM CST
Visgeneer Market Cap
Visgeneer has a market cap or net worth of 258.65 million as of August 18, 2026. Its market cap has decreased by -15.98% in one year.
Market Cap
258.65M
Enterprise Value
315.75M
Revenue
170.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.57
ChartMarket Cap Chart
Since October 24, 2013, Visgeneer's market cap has decreased from 898.66M to 258.65M, a decrease of -71.22%. That is a compound annual growth rate of -9.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 246.58M | -15.77% |
| Dec 31, 2025 | 292.75M | -0.72% |
| Dec 31, 2024 | 294.87M | -8.69% |
| Dec 29, 2023 | 322.94M | 1.90% |
| Dec 30, 2022 | 316.90M | -17.97% |
| Dec 30, 2021 | 386.32M | -8.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NatureWise Biotech & Medicals | 796.11M |
| Taiwan Advance Bio-Pharmaceutical | 782.10M |
| BioLASCO Taiwan | 729.94M |
| SynCore Biotechnology Co.,Ltd | 659.33M |
| MegaPro Biomedical | 656.92M |
| Neith | 633.14M |
| TaiwanJ Pharmaceuticals | 572.07M |
| Vectorite Biomedical | 538.39M |